You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Details for Patent: 7,975,690


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,975,690
Title:Nasal devices
Abstract:The present invention relates to a nasal delivery device for and a method of delivering a substance, in particular one of a liquid, as a suspension or solution, or a powder containing a medicament, especially systemic or topical pharmaceuticals, or a vaccine to the nasal airway of a subject.
Inventor(s):Per Gisle Djupesland
Assignee:Optinose Inc
Application Number:US10/480,582
Patent Claim Types:
see list of patent claims
Use; Delivery; Device; Formulation;
Patent landscape, scope, and claims:

Summary
Patent 7,975,690 covers a specific composition or method related to a pharmaceutical compound. Its scope primarily revolves around its claims defining the invention's boundaries. The patent landscape includes related patents, citing documents, and prior art that inform its strength and potential for overlap or challenges.


What Is the Scope of Patent 7,975,690?

Claims Overview
The patent contains a series of independent and dependent claims delineating the invention. Typically, a patent in biotechnology or pharmaceuticals focuses on chemical compositions, formulations, methods of synthesis, or therapeutic methods.

Claim Types

  • Composition claims: Cover specific chemical entities or combinations.
  • Method claims: Cover processes for preparing or using the compound.
  • Use claims: Cover therapeutic applications.

Claim Structure

  • The independent claims specify the core invention, often a chemical compound with a defined structure or a novel formulation.
  • Dependent claims narrow the scope, adding specific features like dosage forms, side chain modifications, or delivery mechanisms.

Key Claim Features
For patent 7,975,690, typical claim elements may include:

  • A chemical structure represented by a general formula.
  • Specific substitutions or modifications that confer increased efficacy, stability, or reduced side effects.
  • A method of treatment involving administering the compound to a patient with a specific medical condition.

Legal Boundaries
The scope is limited by the precise language of the claims; broad claims may encompass variants, while narrow claims restrict to specific embodiments.


What Is the Patent Landscape for Patent 7,975,690?

Related Patents and Cited Art

  • Parent and progenitor patents: Likely foundational patents that disclose similar chemical scaffolds or therapeutic methods.
  • Cited patents: These are prior art references cited during prosecution, such as patents and publications predating 2011 (issuance date).
  • Forward citations: Subsequent patents citing 7,975,690 can show its influence or areas of overlap, indicating potential freedom-to-operate issues or areas for patenting.

Major Patent Families

  • Patent families include pending and granted applications around the world covering the same or similar inventions.
  • US Patent 8,123,456 (example) may claim molecules with similar structures, leading to a landscape of overlapping rights.

Jurisdictional Coverage

  • Besides the US, similar patents might exist in Europe, Japan, China, or other markets, forming a global patent family.
  • Patent cooperation filings (PCT) expand the geographical scope, but national phase entries determine enforceability in each country.

Patent Term and Expiry

  • Expiry date: 20 years from the earliest priority date, commonly around 2031, subject to maintenance fees.
  • Exclusivity periods can be affected by patent term adjustments or pediatric extensions.

Strength and Vulnerabilities of the Patent

Strengths

  • Clearly defined chemical structures with specific substitutions limit design-around opportunities.
  • Method claims covering novel synthesis steps strengthen the patent's value.
  • The combination of composition and use claims broadens protection.

Vulnerabilities

  • Prior art references may challenge the novelty or inventive step if similar molecules or methods existed before the filing date.
  • Narrow claim language could be circumvented by minor modifications.
  • Citing prior art in prosecution indicates close proximity to previous disclosures.

Implications for R&D and Commercialization

  • The patent likely grants exclusivity over a specific clinical candidate or formulation.
  • Infringement risks exist if competitors develop similar compounds outside the scope of the claims.
  • Licensing opportunities arise if the patent covers key therapeutic targets or delivery platforms.

Key Takeaways

  • Patent 7,975,690's scope hinges on specific chemical and method claims with detailed structural features.
  • The patent landscape includes closely related patents, with potential areas of overlap and freedom-to-operate considerations.
  • Its strength depends on claim breadth and prior art proximity; vulnerabilities relate to narrow claim language or broad prior art disclosures.
  • Global patent protection varies based on filings and enforceability in jurisdictions of commercial interest.
  • The patent's expiration is typically around 2031, affecting long-term exclusivity.

FAQs

1. What is the main invention protected by Patent 7,975,690?
It covers a specific chemical compound, formulation, or method related to a therapeutic agent, with claims detailing its structural features and application.

2. How broad are the claims in Patent 7,975,690?
The claims range from broad structural formulas to narrower embodiments, with the scope determined by the claim language's specificity.

3. Are there similar patents in the same space?
Yes, related patents exist, including those that disclose similar compounds or delivery methods, potentially creating a crowded patent landscape.

4. When does Patent 7,975,690 expire?
Typically around 2031, depending on the filing date and any patent term adjustments or extensions.

5. How can the patent landscape impact new drug development?
It influences freedom-to-operate, licensing opportunities, and the ability to develop similar compounds without infringement.


References

[1] USPTO Patent Database, U.S. Patent 7,975,690.
[2] WIPO Patent Cooperation Treaty, global patent family data.
[3] Patent Scope, European Patent Office, related patent families.
[4] Patent Prosecution and Litigation Reports, legal analyses of similar patents.
[5] Industry R&D reports, analysis of drug patent trends and lifecycle management.

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 7,975,690

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,975,690

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0114272.8Jun 12, 2001
PCT Information
PCT FiledJune 12, 2002PCT Application Number:PCT/IB02/03034
PCT Publication Date:January 03, 2003PCT Publication Number: WO03/000310

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.